Clinical Guides
Hyponatraemia
A review-queue guide to hypotonic hyponatraemia that prioritises neurological severity, tonicity, mechanism and correction safety in Indian clinical practice.
MedNext Academy | 12 min read
Hyponatraemia
A review-queue guide to hypotonic hyponatraemia that prioritises neurological severity, tonicity, mechanism and correction safety in Indian clinical practice.
Summary
Hyponatraemia is a low measured plasma sodium concentration, usually reflecting water excess relative to effective body solute rather than a simple sodium deficit. The first decision is clinical: seizure, coma, markedly reduced consciousness, severe confusion, vomiting with neurological decline or respiratory compromise may reflect cerebral oedema and demand a monitored emergency response. A rapid fall can cause catastrophic symptoms at a value tolerated by someone with chronic adaptation; the sodium number alone cannot grade danger.
The second decision is whether the patient is truly hypotonic. Hyperglycaemia and other effective osmoles move water into extracellular fluid and lower measured sodium; marked lipid or protein excess can produce pseudohyponatraemia with indirect assay methods. In genuine hypotonic hyponatraemia, urine osmolality and urine sodium, drawn with serum samples where possible, are interpreted beside medicines, kidney function, volume physiology and endocrine risk. SIAD is a diagnosis of exclusion, not a label for every person with concentrated urine.
The treatment plan must name both an early clinical aim and a correction ceiling. The European guideline treats a 5 mmol/L rise as an initial symptom-rescue target in severe symptoms, then requires reassessment rather than continued pursuit of a normal sodium concentration. A predicted response is not a safeguard: reversal of hypovolaemia, withdrawal of a causative medicine or steroid replacement can abruptly restore water excretion. Every handover therefore needs the baseline sodium and analytical method, time-stamped results, cumulative change, administered sodium and potassium, urine output, and the escalation threshold.
Treatment can injure as well as help. Hypertonic saline treats dangerous cerebral oedema, not a laboratory target. Once an initial symptom-directed increment is reached, stop, identify the mechanism and watch sodium, potassium, urine output and fluid balance closely. This review candidate cannot replace a locally approved protocol or senior clinical judgement. [European guideline, sections 5, 6 and 7]
How Common Is It?
Hyponatraemia is common in acute and inpatient medicine, but its measured frequency depends on who is tested, which threshold is used and when the sample is drawn. Rates differ substantially among ambulatory patients, emergency attendances, postoperative wards and critical-care populations. A foreign ward prevalence should not be presented as Indian national epidemiology. It is safer to describe the clinical contexts in which a low result is often encountered and to separate a biochemical observation from a defined hypo-osmolar syndrome.
It commonly appears with infections, surgery, gastrointestinal loss, heart or liver failure, chronic kidney disease, central nervous system disease and medicines that affect water handling. Testing is more frequent in older adults and people receiving intravenous fluids or diuretics, which influences apparent burden. A laboratory low sodium may also be explained by hyperglycaemia or analytical pseudohyponatraemia; counting these together inflates any claim about hypotonic hyponatraemia.
A meaningful local audit records symptoms, measured osmolality, glucose, medicines, urine studies, presumed mechanism, correction trajectory and outcome. It should also capture whether sodium could be repeated fast enough for the treatment given. Epidemiology never changes the immediate priority of stabilising a patient with seizure or deteriorating consciousness. [European guideline, introduction and sections 5.1 to 5.3]
Risk Factors
Risk factors are best understood as reasons the kidney cannot excrete water or reasons effective arterial volume is low. Thiazide and thiazide-like diuretics are important contributors. Other medicines that may matter include selective serotonin-reuptake inhibitors, carbamazepine, oxcarbazepine, antipsychotics, opioids, desmopressin and some anticancer therapies. Record the exact dose, start date and recent changes, together with non-prescribed or traditional preparations and all intravenous fluid already received. Withdrawal of a reversible trigger can cause water diuresis and thus become a correction-risk event.
Vomiting, diarrhoea, burns, renal salt loss and adrenal insufficiency may cause hypovolaemic physiology. Heart failure, cirrhosis and nephrotic disease can have total-body water and sodium excess with reduced effective arterial volume. Pain, nausea, postoperative stress, lung disease and central nervous system disease stimulate vasopressin. High water intake and very low solute intake create a different mechanism, often with dilute urine until acute illness or medication adds vasopressin activity.
Risk of osmotic demyelination after correction rises with profound or likely chronic hyponatraemia, alcohol use disorder, malnutrition, advanced liver disease and hypokalaemia. These factors lower the permitted correction ambition; they do not justify delaying emergency treatment for seizures. [European guideline, sections 5.5 to 5.8 and 7.4.1]
Diagnosis
History
Establish onset from prior sodium values, symptom timing and recent events. Ask about headache, nausea, vomiting, thirst, water and alcohol intake, diet, urine volume, falls, gait or attention change, seizure, infection, surgery, severe pain and recreational-drug exposure. Reconcile every medicine and fluid. Ask about diabetes, renal, liver, cardiac, pituitary and adrenal disease. If no prior value or precipitating event is known, duration is unknown; do not call it chronic simply because symptoms are mild.
Examination
Assess airway, breathing, circulation, glucose, consciousness and seizure activity first. Look for focal neurology and alternative causes of encephalopathy. Then examine perfusion, postural symptoms, mucous membranes, jugular venous pressure, oedema, ascites, chest signs, body weight where useful and evidence of infection, heart failure, liver disease or adrenal crisis. Volume examination is imperfect and cannot replace the history and paired biochemical data.
Investigations
Repeat sodium and obtain glucose, measured serum osmolality, potassium, urea, creatinine, paired urine osmolality and urine sodium. Take diagnostic samples before treatment only if doing so does not delay resuscitation. Consider lipids or protein, cortisol, thyroid testing and focused pulmonary, infectious or neurological tests when clinically indicated. Urine osmolality at or below 100 mOsm/kg suggests maximally dilute urine; above that, urine sodium and context guide the next branch. [European guideline, section 6.3.1]
Differential Diagnosis
Begin with tonicity. Hyperglycaemia produces translocational hyponatraemia; administered osmoles can do the same. Pseudohyponatraemia is a laboratory measurement problem in marked lipid or protein excess and is not corrected with saline. Measured osmolality prevents a wrong treatment pathway. In confirmed hypotonicity, urine osmolality identifies whether vasopressin is suppressed or water excretion is limited, but a result after saline, diuretics or acute illness is not self-explanatory.
Hypovolaemic hypotonic hyponatraemia can follow gastrointestinal, renal or skin sodium loss. Hypervolaemic physiology occurs in heart failure, cirrhosis and nephrotic disease. Advanced kidney impairment limits free-water clearance and makes simple urine-sodium thresholds unreliable. Apparent euvolaemia includes SIAD, glucocorticoid deficiency, severe hypothyroidism, low-solute intake, primary polydipsia and reset osmostat. SIAD requires hypotonicity, inappropriately concentrated urine, compatible urine sodium and exclusion of adrenal, thyroid, renal and volume causes.
Mixed mechanisms are common: for example, pneumonia, thiazide exposure and poor intake can coexist. A neurological diagnosis does not prove cerebral salt wasting. Also assess other causes of the symptom attributed to sodium, including hypoglycaemia, hypercapnia, intoxication, stroke, infection and epilepsy. [European guideline, sections 5.1 to 5.8]
Management
Treat severe neurological symptoms in a monitored environment. The European guideline recommends intravenous 150 mL 3% hypertonic saline over 20 minutes, with sodium measurement and repeated boluses up to two further times until symptoms improve or sodium has risen by about 5 mmol/L. This is a symptom-rescue target, not a licence to normalise sodium. Stop hypertonic saline after the target response, investigate other causes if symptoms persist and arrange intensive clinical and biochemical observation. A local adult protocol may specify another bolus volume; use the approved local pathway rather than improvising the solution.
Then treat the mechanism. Restore effective volume with isotonic crystalloid in genuine hypovolaemia, anticipating brisk water diuresis as vasopressin falls. Remove reversible SIAD triggers and use an individualised, specialist-supported strategy; fluid restriction only helps when it creates negative water balance and is not an automatic response to every low sodium. Heart failure, cirrhosis and kidney disease require disease-specific management. Do not use hypertonic saline for an asymptomatic number.
For moderate or profound chronic or unknown-duration hyponatraemia without severe symptoms, avoid an increase above 10 mmol/L in the first 24 hours and 8 mmol/L in each later 24 hours. Check sodium at least six-hourly until stable under stable treatment. Potassium replacement contributes to correction and belongs in the same plan. [European guideline, sections 7.1.1 and 7.4.1]
Prescribing Information
A hypertonic-saline order must state the local 3% sodium chloride product, dose, administration time, baseline and post-dose sodium, neurological observations, infusion stop point, fluid-balance requirements and escalation clinician. Do not compound concentrated saline from memory. The cited 150 mL adult regimen is not a paediatric, pregnancy or renal-unit prescription. During active correction, a sudden increase in dilute urine is a warning that sodium may rise unexpectedly; recheck promptly and review every source of sodium, potassium and free water.
If sodium rises more than 10 mmol/L in the first 24 hours or more than 8 mmol/L in any later 24 hours, stop active sodium-raising treatment and obtain urgent expert help. The European guideline recommends discussing infusion of electrolyte-free water such as 5% glucose 10 mL/kg over one hour under strict monitoring, and intravenous desmopressin 2 micrograms no more often than every eight hours. These are experienced-hands rescue measures, not standing orders.
Do not start a vaptan, oral urea, salt regimen or loop-diuretic strategy merely because a sodium result is low. Product approval, contraindications, access and monitoring requirements vary. Consult the local formulary and specialist team, especially in liver disease, kidney failure, inability to drink to thirst or high overcorrection risk. [European guideline, section 7.5; treatment standard 2024]
When to Refer
Escalate immediately to emergency, critical-care, nephrology or endocrinology support for seizure, coma, severe confusion, rapidly falling sodium, respiratory compromise, need for hypertonic saline or inability to monitor sodium and urine output frequently. Begin the locally approved emergency pathway and transfer in parallel; a diagnostic label must not delay stabilisation. Lower the threshold for higher-level care where laboratory turnaround, monitored beds or trained nursing observation is limited.
Seek specialist input for suspected adrenal crisis or hypopituitarism, recurrent unexplained hypotonic hyponatraemia, suspected SIAD without a clear trigger, complex heart, liver or kidney disease, pregnancy, severe diuretic problems, low-solute states or consideration of vaptans, urea, loop diuretics or desmopressin. Failure to behave as predicted suggests a mixed mechanism or incorrect diagnosis and deserves reassessment rather than escalating an unverified treatment.
Any overcorrection, brisk aquaresis after volume or steroid replacement, or evolving neurological deficit after correction is urgent. Track the cumulative change from the true baseline, not merely the last result, and involve an experienced clinician in a re-lowering decision. [Society for Endocrinology emergency guidance; European guideline, section 7.5]
Red Flags
Seizure, coma, striking reduction in consciousness, severe agitation or confusion, vomiting with neurological decline or cardiorespiratory distress in a patient with low sodium is possible hyponatraemic encephalopathy. Stabilise airway and circulation, check glucose, obtain urgent samples if feasible and use the local hypertonic-saline pathway without waiting for a complete aetiological work-up. Persisting symptoms after an initial sodium increment demand renewed investigation for another neurological, metabolic or toxic cause.
A documented fall within 48 hours, postoperative hypotonic-fluid exposure, excessive water intake with acute illness, MDMA exposure or desmopressin use raises concern for acute hyponatraemia. In most patients duration is uncertain, so correction ceilings still protect against osmotic injury. Shock, severe diarrhoea, hypoglycaemia, hyperpigmentation or pituitary features should trigger urgent evaluation for adrenal insufficiency.
During treatment, copious dilute urine, a sodium rise nearing the daily limit, inadequate sampling capacity or unrecorded potassium replacement signals iatrogenic danger. Alcohol use disorder, malnutrition, liver disease and hypokalaemia further increase concern. Document total administered fluid, urine volume and every sodium result before a handover: an apparently stable patient can cross a correction limit after the causal stimulus has changed. [Society for Endocrinology emergency guidance; European guideline, section 7.5]
Indian Clinical Context
This draft uses international adult guidance because it does not identify a current India-wide protocol that standardises hypertonic-saline bolus volume, laboratory frequency and re-lowering therapy across all settings. That is an evidence and jurisdiction limit. Before treatment, confirm the concentration and labelling of locally stocked saline, the availability of urgent sodium measurement and the environment in which neurological status and urine output can be observed. A foreign guideline cannot substitute for a hospital order set.
Presentations in India may include diarrhoeal loss, pulmonary or central nervous system infection, tuberculosis-related disease, diuretic exposure, liver disease, heat-related excess water intake and uneven access to monitoring. None proves SIAD. In diarrhoeal hypovolaemia, resuscitation and infection assessment come first. When tuberculosis is considered, investigate the pulmonary, meningeal or adrenal syndrome rather than assuming one water-handling mechanism. Oral rehydration products and intravenous fluids are not interchangeable; check the actual composition.
NMC curriculum material supports supervised learning rather than independent prescribing. Escalation and transfer thresholds should be lower where hypertonic saline, critical care, endocrine tests or repeat sodium measurement are unavailable. [NMC CBME Curriculum 2024, undergraduate framework]
NMC Competency Mapping
Hyponatraemia links osmolality and vasopressin physiology to general medicine, nephrology, endocrinology, emergency care, pharmacology and laboratory medicine. The NMC CBME Curriculum 2024 is the governing undergraduate framework, but this draft does not fabricate a condition-specific competency number or claim certification. Institutions should map the encounter to their presently approved local ledger and level of supervision.
At knowledge level, learners should explain why low sodium is not automatically sodium deficiency, distinguish measured osmolality from assumptions, identify non-hypotonic mimics and describe why acuity changes urgency. At reasoning level, they should obtain a timeline, reconcile medicines and fluids, interpret paired serum and urine tests, recognise possible adrenal insufficiency and avoid prematurely calling SIAD.
Under supervision, learners should assess consciousness and seizure activity, document fluid balance, communicate why a correction ceiling protects the brain and escalate a large dilute diuresis. They should not independently compound hypertonic saline or prescribe rescue desmopressin. An assessment should reward safe triage, uncertainty, cumulative correction calculation and referral rather than a memorised list. [NMC CBME Curriculum 2024, curriculum and assessment framework]
Key Exam Pearls for NEET PG
Use a sequence, not a mnemonic alone. Confirm whether hyponatraemia is hypotonic; hyperglycaemia can lower measured sodium through water shift and pseudohyponatraemia is analytical. In hypotonic states, urine osmolality at or below 100 mOsm/kg suggests maximally dilute urine. Above that, urine sodium is interpreted with clinical volume, kidney function, diuretics and timing of fluids.
Do not let volume classification erase emergency care. Seizure, coma or severe neurological deterioration can justify prompt 3% saline before the full cause is known. The early aim is clinical improvement or an increment of about 5 mmol/L, then stop hypertonic saline and reassess. For moderate or profound chronic or unknown-duration cases, the European ceiling is 10 mmol/L in the first 24 hours and 8 mmol/L in every later 24-hour period.
Osmotic demyelination follows excessive correction, particularly with alcohol use disorder, malnutrition, liver disease or hypokalaemia. If the ceiling is exceeded, stop active correction, call an expert and consider controlled 5% glucose plus desmopressin under strict monitoring. [European guideline, sections 6.3.1, 7.1.1, 7.4.1 and 7.5]
Frequently Asked Questions
Why can someone with a modestly low sodium result be very unwell?
Risk follows the speed of the fall and effective tonicity, not one number. An abrupt hypotonic fall can cause cerebral oedema, seizure or coma at a concentration tolerated by another person with chronic adaptation. Compare prior values, assess neurological severity and measure osmolality. Severe symptoms need immediate monitored treatment while the cause is clarified. The emergency decision is therefore based on current neurological state, documented trajectory and plausible causation; it should not be delayed while clinicians wait to cross an arbitrary sodium threshold or complete a full volume classification.
Does every low sodium result require a fluid restriction?
No. Fluid restriction may help selected chronic SIAD-type states but can harm hypovolaemia and does not treat cerebral oedema. Gastrointestinal sodium loss may need isotonic volume replacement; heart or liver failure needs disease-specific care; hyperglycaemia needs treatment of glucose; and pseudohyponatraemia needs no sodium correction. The plan follows physiology and monitoring capacity. A written restriction must count every drink, soup and enteral-water flush, be matched to urine and insensible losses, and be reviewed if thirst, hypotension, acute kidney injury or an evolving diagnosis makes restriction unsafe.
What should happen if sodium is correcting faster than planned?
Treat this as urgent iatrogenic risk. Stop active sodium-raising treatment, check the cumulative change from baseline and review urine output, potassium, fluids and the trigger for water diuresis. The European guideline advises expert discussion when the increase exceeds 10 mmol/L in the first 24 hours or 8 mmol/L later; controlled electrolyte-free water and desmopressin may be used under strict monitoring. Record the time and analytical method of each sodium result, because acting on a mis-timed sample or switching methods can create a false appearance of acceleration.
Can SIAD be diagnosed from one concentrated urine sample?
No. Concentrated urine only shows limited water excretion. Pain, nausea, hypovolaemia, medicines, kidney disease and adrenal insufficiency can produce that result. SIAD requires hypotonicity, inappropriate concentration, compatible urine sodium and exclusion of thyroid, adrenal, renal and volume causes. Samples after treatment may be particularly difficult to interpret. Reassess the diagnosis when saline, glucocorticoid replacement or withdrawal of an offending medicine produces a response that does not fit the original working mechanism.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic